Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Takeda Pharmaceutical Co. Ltd. 

1-1, Doshomachi 4-chome

Chuo-ku  Osaka  540-8645  Japan
Phone: 81-6-6204-2111 Fax: 81-6-6204-2880


 Key Statistics

Email: n/a
Ownership: Public

Web Site: Takeda Pharmaceutical Co. Ltd.
Symbol: TKPYY


 Company News
German Database Study Hints Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Diabetes Drug Cuts Alzheimer's Risk 7/14/2014 7:29:54 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) And Zinfandel Pharmaceuticals Inc. To Present Data At Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches To Alzheimer's Disease Research And Development 7/10/2014 10:43:47 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) COO Dreams Big, Seeks Deals And Global Push In Turnaround Effort 7/3/2014 8:10:29 AM
Ex-Employees, Investors Attack Takeda Pharmaceutical Co. Ltd. (TKPYY) For Hiring Foreign Executives 6/23/2014 6:35:58 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Legal-Bay Lawsuit Settlement Funding Reports $9 Billion In The First Actos (Pioglitazone) Settlement 6/19/2014 6:35:56 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/19/2014 6:09:16 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Results Of A New Study Of Brintellix® (vortioxetine) vs. Escitalopram On Sexual Functioning In Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction 6/17/2014 11:03:37 AM
Affymax, Inc. (AFFY) Drug Omontys® Terminal As Takeda Pharmaceutical Co. Ltd. (TKPYY) Switches Off Support 6/16/2014 10:49:39 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014 8:42:10 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release:New CONNECT Study Presents Data On Measures Of Cognitive Performance In Adult Patients Treated With Brintellix® (Vortioxetine) For Major Depressive Disorder 6/16/2014 7:27:53 AM